Pustular Psoriasis: The Dawn of a New Era

Acta Derm Venereol. 2020 Jan 30;100(3):adv00034. doi: 10.2340/00015555-3388.

Abstract

Pustular psoriasis is a clinically heterogeneous entity of different, orphan disease subtypes, among which the most clearly defined are generalized pustular psoriasis, palmoplantar psoriasis, and acrodermatitis continua of Hallopeau. Although phenotypically and genetically distinct from psoriasis vulgaris, these subtypes may be associated with plaque psoriasis lesions, establishing the rationale for their inclusion in the psoriasis spectrum. Unlike psoriasis, however, their genetic background is thought to be mainly monogenic, as shown by the recent identification of mutations in 3 different genes of the skin innate immune system; IL36RN, CARD14 and AP1S3. These major advances in the understanding of the disease pathogenesis have led to the design and ongoing development of tailored therapeutic approaches, which are highly necessary given the refractory nature of pustular psoriasis in response to most available antipsoriatic drugs.

Keywords: generalized pustular psoriasis; interleukin-36; palmoplantar pustulosis; pustular psoriasis; pustulosis.

Publication types

  • Review

MeSH terms

  • CARD Signaling Adaptor Proteins / genetics
  • Diagnosis, Differential
  • Guanylate Cyclase / genetics
  • Humans
  • Interleukins / genetics
  • Membrane Proteins / genetics
  • Phenotype
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Psoriasis / genetics*
  • Psoriasis / immunology
  • Vesicular Transport Proteins / genetics

Substances

  • AP1S3 protein, human
  • CARD Signaling Adaptor Proteins
  • IL36RN protein, human
  • Interleukins
  • Membrane Proteins
  • Vesicular Transport Proteins
  • CARD14 protein, human
  • Guanylate Cyclase